Advisor Group Holdings, Inc. Apellis Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,114 shares of APLS stock, worth $70,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,114
Previous 2,272 6.95%
Holding current value
$70,057
Previous $87,000 31.03%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$28.84 - $41.15 $4,556 - $6,501
-158 Reduced 6.95%
2,114 $60,000
Q2 2024

Aug 13, 2024
SELL
$38.07 - $59.71 $27,753 - $43,528
-729 Reduced 24.29%
2,272 $87,000
Q1 2024

May 10, 2024
SELL
$55.39 - $72.47 $165,616 - $216,685
-2,990 Reduced 49.91%
3,001 $176,000
Q4 2023

Feb 12, 2024
SELL
$37.14 - $64.82 $2,228 - $3,889
-60 Reduced 0.99%
5,991 $358,000
Q3 2023

Nov 13, 2023
BUY
$23.65 - $89.22 $25,589 - $96,536
1,082 Added 21.78%
6,051 $230,000
Q2 2023

Aug 10, 2023
SELL
$76.68 - $93.31 $710,670 - $864,797
-9,268 Reduced 65.1%
4,969 $452,000
Q1 2023

May 12, 2023
BUY
$46.59 - $66.96 $511,930 - $735,756
10,988 Added 338.2%
14,237 $939,000
Q4 2022

Feb 10, 2023
BUY
$43.24 - $61.04 $9,037 - $12,757
209 Added 6.88%
3,249 $168,000
Q3 2022

Nov 14, 2022
BUY
$44.76 - $69.66 $16,695 - $25,983
373 Added 13.99%
3,040 $209,000
Q2 2022

Aug 10, 2022
BUY
$35.07 - $59.21 $2,174 - $3,671
62 Added 2.38%
2,667 $120,000
Q1 2022

May 04, 2022
SELL
$35.46 - $54.12 $49,502 - $75,551
-1,396 Reduced 34.89%
2,605 $132,000
Q3 2021

Nov 05, 2021
BUY
$31.4 - $69.84 $56,143 - $124,873
1,788 Added 80.8%
4,001 $132,000
Q2 2021

Aug 02, 2021
BUY
$40.9 - $64.9 $286 - $454
7 Added 0.32%
2,213 $139,000
Q1 2021

May 13, 2021
SELL
$40.8 - $57.39 $3,671 - $5,165
-90 Reduced 3.92%
2,206 $95,000
Q4 2020

Feb 10, 2021
SELL
$30.79 - $57.2 $3,079 - $5,720
-100 Reduced 4.17%
2,296 $131,000
Q2 2020

Aug 14, 2020
SELL
$24.8 - $38.49 $3,968 - $6,158
-160 Reduced 6.26%
2,396 $78,000
Q1 2020

May 18, 2020
BUY
$17.91 - $44.33 $45,777 - $113,307
2,556 New
2,556 $68,000

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email